Are we doing enough to stem the tide of acquired MDR-TB in countries with high TB burden? Results of a mixed method study in Chongqing, China

• Published in: PloS one 2014-02, Vol.9 (2), p.e88330-e88330
• Main Authors: Li, Ying, Ehiri, John, Oren, Eyal, Hu, Daiyu, Luo, Xingneng, Liu, Ying, Li, Daikun, Wang, Qingya
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Analysis; China - epidemiology; Cost of Illness; Cross-Sectional Studies; Delay; Directly Observed Therapy; Disease control; Disease prevention; Drug resistance; Female; Health care; Health care facilities; Health care industry; Health promotion; Health risks; Health services; HIV; Hospital facilities; Human immunodeficiency virus; Humans; Male; Medical diagnosis; Medical personnel; Medical research; Medicine; Methods; Middle Aged; Mixed methods research; Multidrug resistance; Occupational health; Patient Education as Topic; Patients; Prevention; Public health; Qualitative analysis; Qualitative research; Risk factors; Risk taking; Socioeconomic Factors; Studies; Surveys; Surveys and Questionnaires; Systematic review; Tuberculosis; Tuberculosis, Multidrug-Resistant - economics; Tuberculosis, Multidrug-Resistant - epidemiology; Tuberculosis, Multidrug-Resistant - therapy; Tuberculosis, Pulmonary - economics; Tuberculosis, Pulmonary - epidemiology; Tuberculosis, Pulmonary - therapy; Workers; Young Adult
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0088330

Multi-drug resistant tuberculosis (MDR-TB) represents a threat to health and development in countries with high TB burden. China's MDR-TB prevalence rate of 6.8% is the highest in the world. Interventions to remove barriers against effective TB control, and prevention of MDR-TB are urgently needed in the country. This paper reports a cross-sectional questionnaire survey of 513 pulmonary TB (PTB) patients, and qualitative interviews of 10 healthcare workers (HCWs), and 15 PTB patients. The objective was to assess barriers against effective control of PTB and prevention of MDR-TB by elucidating the perspectives of patients and healthcare providers. Results showed that more than half of the patients experienced patient delay of over 12.5 days. A similar proportion also experienced detection delay of over 30 days, and delay in initiating treatment of over 31 days. Consulting a non-TB health facility ≥3 times before seeking care at TB dispensary was a risk factor for both detection delay [AOR (95% CI): 1.89(1.07, 3.34) and delay in initiating treatment[AOR (95% CI): 1.88 (1.06, 3.36). Results revealed poor implementation of Directly Observed Therapy (DOT), whereby treatment of 34.3% patients was never monitored by HCWs. Only 31.8% patients had ever accessed TB health education before their TB diagnosis. Qualitative data consistently disclosed long patient delay, and indicated that patient's poor TB knowledge and socioeconomic barriers were primary reasons for patient delay. Seeking care and being treated at a non-TB hospital was an important reason for detection delay. Patient's long work hours and low income increased risk for treatment non-adherence. Evidence-based measures to improve TB health seeking behavior, reduce patient and detection delays, improve the quality of DOT, address financial and system barriers, and increase access to TB health promotion are urgently needed to address the burgeoning prevalence of MDR-TB in China.